Trial record 1 of 1 for:    NCT00320138
Previous Study | Return to List | Next Study

Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00320138
Recruitment Status : Completed
First Posted : May 3, 2006
Last Update Posted : January 12, 2012
Federal government (congressional allocation)
Information provided by (Responsible Party):
Charles Engel, Uniformed Services University of the Health Sciences

April 27, 2006
May 3, 2006
January 12, 2012
March 2006
October 2007   (Final data collection date for primary outcome measure)
PTSD Checklist (PCL) [ Time Frame: baseline, 1 month, 2 months, and 3 months ]
The PCL is a widely used measure of PTSD symptom presence and severity among veterans. It is a 17-item measure that assesses the symptoms of PTSD listed in the DSM-IV. Respondents indicate on a 5-point scale (1-5) the degree to which they have been bothered by each symptom in the past month. The PCL-M yields a total severity score ranging from 17 to 85.
PTSD Checklist (PCL): baseline, 1 month, 2 months, and 3 months
Complete list of historical versions of study NCT00320138 on Archive Site
  • Clinician-Administered PTSD Scale [ Time Frame: baseline, 3 months ]
    The CAPS is a 30 item, clinician-administered structured interview that is often referred to as the "gold standard" for diagnosing PTSD. The CAPS measures PTSD and ASD symptoms (based on the DSM-IV symptom criteria) related to up to three traumatic events. Higher scores indicate more intense and more frequent symptoms of PTSD, while lower scores represent the absence of or less intense, less frequent symptoms of PTSD. The CAPS was used in this study as the primary diagnostic tool for PTSD at entry into the study and at the three-month follow-up, and will help validate scores on the PCL.
  • The Trauma History Questionnaire [ Time Frame: baseline, 3 months ]
    ]. This 24 item self-report questionnaire was designed to assess lifetime history of exposure to 23 potentially traumatic experiences including crime, disaster, and physical and sexual assaults It also contains an open-ended question for specifying other extraordinarily stressful situations or events. The data acquired using this instrument will be used to provide general data about the study sample. Additionally, the THQ will be administered at the three-month follow-up to assess the occurrence of traumatic events during the course of the study.
  • SF-36-Revised [ Time Frame: baseline, 3 months ]
    The SF-36-Revised measures eight general health-related concepts, which have been shown to load into distinct physical and mental health clusters in factor analytic studies in the general population. The eight scales within the SF-36-Revised are: Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional and Mental Health (psychological distress and psychological well-being).
  • Beck Depression Inventory [ Time Frame: baseline, 1 month, 2 months, 3 months ]
    The BDI-II is a 21-item self-report measure that evaluates symptoms of depression. Each item is scored on a scale from 0 to 3. Total scores on BDI range from 0 to 63, with scores of less than 15 indicating normal to mild depression, scores of 15 to 30 indicating moderate depression, and scores above 30 constituting severe depression.
  • Numeric Rating Scale for Pain [ Time Frame: baseline, 1 month, 2 months, 3 months ]
    The NRS directs participants to rate pain intensity using three, 11-point, 0 ("no pain") to 10 ("pain as bad as you can imagine") numeric rating scales. Instructions ask participants to "Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours", pain "at its worst", and "pain at its least". The NRS was used in this study to evaluate the effect of acupuncture on comorbid symptoms of pain.
  • PTSD Life Chart Method (PTSD-LCM) [ Time Frame: tracked daily throughout 3-month study period ]
    The life-chart method is a means of illustrating the relationship of life events and treatment interventions to the longitudinal course of illness. The PTSD-LCM was designed to prospectively track primary symptoms of PTSD as well as comorbid symptoms on a daily basis. The PTSD-LCM incorporates the Ecological Momentary Assessment method in a paper-and-pencil format.
  • Alcohol Use Disorder Identification Test [ Time Frame: baseline, 3 months ]
    The AUDIT was developed by the World Health Organization to identify hazardous and harmful alcohol use in adults and to serve as a brief (10-item) screening instrument for excessive drinking. It was intended to identify a broad spectrum of problem drinkers and distinguish them from both hospitalized alcoholics and from normal drinkers. The instrument was modified for our purposes to inquire about participants' behavior since returning from deployment. It was used to evaluate the effect of acupuncture on comorbid symptoms of alcohol abuse.
  • Diagnostic evaluation by blind assessing acupuncturist [ Time Frame: baseline, 1 month ]
    The Assessing Acupuncturist examined the patient using TCM diagnostic criteria before the first treatment, after the first four (standardized) treatments, and again at the conclusion of treatment (after the four individualized treatments). The Assessing Acupuncturist will be blind to the treatment conditions. Identical diagnostic procedures were used for patients in the treatment group and in the wait list control group. Evaluations by the Assessing Acupuncturist were be audio-recorded to ensure that they remain blind to the treatment conditions.
  • Clinician-Administered PTSD Scale: baseline, 3 months
  • The Trauma History Questionnaire: baseline, 3 months
  • SF-36-Revised: baseline, 3 months
  • Beck Depression Inventory: baseline, 1 month, 2 months, 3 months
  • Numeric Rating Scale for Pain: baseline, 1 month, 2 months, 3 months
  • PTSD Life Chart Method (PTSD-LCM): tracked daily throughout 3-month study period
  • Alcohol Use Disorder Identification Test: baseline, 3 months
  • Diagnostic evaluation by assessing acupuncturist: baseline, 1 month
Not Provided
Not Provided
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
Acupuncture for the Treatment of Trauma Survivors
The purpose of this study is to determine the effectiveness of acupuncture as a treatment for Posttraumatic Stress Disorder (PTSD) among military personnel.
Untreated Posttraumatic Stress Disorder (PTSD) leads to decreased force readiness and increased health care utilization. Yet, service members with the disorder may be resistant to traditional treatments or find them undesirable because of side-effects, stigma, and long-term commitment. Acupuncture, which has few known side effects, holds promise as an effective treatment option for PTSD. Acupuncture has been shown to improve well-being and has been successfully used to treat stress, anxiety and pain conditions. In order to test the efficacy of acupuncture for treating the symptoms of PTSD—measured by the PTSD Checklist (PCL)—a 12-week, randomized, waitlist-controlled trial will be conducted using a sample of 75 active duty military personnel. Participants will receive an eight-session acupuncture treatment, and will be evaluated throughout the study by way of clinical assessments and an independent assessing acupuncturist.
Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Posttraumatic Stress Disorder (PTSD)
Procedure: Acupuncture, using Chinese Medicine methodology
4 weeks of 2/week treatments (8 total); 4 standardized and 4 individualized treatments
  • Active Comparator: Acupuncture
    Intervention: Procedure: Acupuncture, using Chinese Medicine methodology
  • No Intervention: Wait List
    Usual Care
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
October 2007
October 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Active duty military personnel
  • Criteria met for PTSD based on Clinician-Administered PTSD Scale (CAPS) interview
  • A stable medication dosing regimen or therapeutic treatment schedule for at least eight (8) weeks prior to beginning the study.

Exclusion Criteria:

  • Acupuncture treatment within the previous 6 months
  • Pain greater than or equal to level 8 on the Numeric Rating Scale for Pain
  • Significant head injury with loss of consciousness greater than 1 hour
  • Uncontrolled diabetes mellitus: fasting blood glucose >180 mg/dl
  • Unstable or uncontrolled endocrine disorders, thyroid disease, renal failure, anemia, hemorrhagic diathesis, renovascular disease, Cushing's disease, or hyperaldosteronism
  • Unwillingness on the part of participants to complete all study visits and/or the daily Life Chart
  • Pregnancy
  • Scheduled surgery during the treatment phase of the study
  • Medical instability sufficient to warrant inpatient treatment in the medical or intensive care units
  • Psychiatric symptoms sufficient to warrant inpatient treatment by the clinical care team
  • Psychosis within the past two years
  • A traumatic experience, as defined by the DSM-IV criterion A for ASD/PTSD, within the past 30 days
Sexes Eligible for Study: All
18 Years to 60 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Charles Engel, Uniformed Services University of the Health Sciences
Henry M. Jackson Foundation for the Advancement of Military Medicine
Federal government (congressional allocation)
Principal Investigator: Charles C Engel, MD, MPH USUHS Dept. of Psychiatry/DoD Deployment Health Clinical Center, Walter Reed National Military Medical Center
Henry M. Jackson Foundation for the Advancement of Military Medicine
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP